Search Results - kenneth+hensley

2 Results Sort By:
Novel Compounds in Treating Autophagy-Related Pathologies
Project IDs: D2015-09 and D2016-81 Autophagy is a self-degradation process of cellular organelles that helps defend against metabolic stress, maintain metabolic equilibrium, arbitrate cell fate decisions, and safeguard genomic stability. Deficient autophagy has been associated with over 100 diseases, and experimental enhancement of autophagy often...
Published: 4/6/2026   |   Updated: 4/3/2019   |   Inventor(s): Kenneth Hensley, Travis Denton
Keywords(s): ALS, Alzheimer's, Autophagy, Lanthionine Ketimine, Parkinson's
Category(s): Neuroscience
Novel agents and methods for treating neurodegenerative disorders
Project ID: D2013-69 Midi-GAGR has several desired properties (neurotrophic, anti-oxidant, non-cytotoxic, anti-inflammatory, and BBB-permeable) for treatment of neurodegenerative diseases. Such materials have been shown to cross the blood-brain barrier, reduce the degeneration of cortical, peripheral, and dopaminergic nerve cells under pathogenic...
Published: 4/15/2026   |   Updated: 6/17/2015   |   Inventor(s): Joshua Park, Dong Shik Kim, Kenneth Hensley
Keywords(s): ALS, Alzheimer’s disease, Blood-brain Barrier, Brain Trauma, Neuritogenesis, Neurodegenerative, Neuroprotective, Spinal, Spinal Cord Injury
Category(s): Neuroscience